Discontinuation report APO-RISEDRONATE

Last updated on 2018-10-19 History
Report ID 64965
Drug Identification Number 02353687
Brand name APO-RISEDRONATE
Common or Proper name RISEDRONATE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) RISEDRONATE SODIUM
Strength(s) 35MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BTL
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-10-18
Remaining supply date 2018-10-18
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-10-19 French Compare
v1 2018-10-19 English Compare